GLP-1 Drugs Linked to 73% Fewer Bleeding Hospitalizations in Angiodysplasia Patients in Early, Unpublished ACG Meeting Data

4,000 Brigham and Women’s Nurses Postpone Wednesday Strike to Vote on Hospital’s Best and Final Contract OfferBrigham and Women’s nurses postponed the Oct. 14 strike to vote on a final offer. See the pay, insurance, and staffing terms, and what patients face. Parents Should Check Amazon Bath Seats and Dressers, Giant Bike Lock Keys, and Avengers Medals in New RecallsNew CPSC recalls cover Amazon baby bath seats and dressers, Giant LED bike lock keys, and Avengers medals. See what you own and how to get refunds. Chicago Marathon’s Record Field of More Than 55,000 Faces a Yellow-Flag Day with Highs Near 71 DegreesThe Chicago Marathon starts under a yellow flag with a forecast high near 71, above the 65-degree normal. Heat illness signs and when to stop. Records Detail Immediate Jeopardy Citation After Charlotte Nursing Home Resident in Wheelchair Was Fatally Struck in 2023Records show inspectors cited a Charlotte nursing home at the immediate jeopardy level after a resident in a wheelchair was fatally struck on a busy road. Mental Health Frequent Mental Distress in Adults 18 to 29 Climbed From 12.7% to 21.3% Since 2012 Despite Recent DeclinesCDC data show 1 in 5 adults 18 to 29 report frequent mental distress, up from 2012 but down two years straight. Where to find help today. A Strong Smell Could Set Off His Sneezing Fits, but His Muscles Told a Stranger StoryStrong smells set off a teacher’s sneeze-like fits for nine years. Muscle recordings showed rapid jerks unlike a textbook sneeze reflex. Louisiana Finds New Synthetic Opioid Cychlorphine in at Least Two Deaths, Warns Extra Naloxone Doses May Be NeededLouisiana found cychlorphine in at least two overdose deaths since December 2025. See where the opioid has spread and why naloxone may need repeating. Utah Links Four Deaths to Opioid-Like Kratom Chemicals Found in Products Labeled Cat’s Claw and Kratom SupplementsUtah ties four deaths to MGPI and MGM-15, kratom-derived opioids found in products labeled cat’s claw. Here’s what buyers should check now. Innovation No Measles, Mumps or Chickenpox Cases Followed Accidental Live Vaccines in 220 IBD Patients on Immune-Modifying DrugsNo measles, mumps, or chickenpox cases followed accidental live vaccine administration in 220 IBD patients on immunosuppressive drugs. Why live shots are still avoided. GLP-1 Drugs Linked to 73% Fewer Bleeding Hospitalizations in Angiodysplasia Patients in Early, Unpublished ACG Meeting DataGLP-1 drugs were linked to 73% fewer GI bleeding hospitalizations in angiodysplasia patients in early ACG data. What it does and does not prove. Argenx Stops Phase 3 Vyvgart Trial in Sjögren’s Disease After Monitors Find the Study Cannot Meet Its GoalArgenx ended its Phase 3 UNITY trial of efgartigimod in Sjögren’s disease after a futility review. No new safety signals were found. Gene Therapy Paired with Special Goggles Improved Light Sensitivity in 7 of 10 Blind Retinitis Pigmentosa PatientsAn optogenetic gene therapy used with special goggles improved light sensitivity in 7 of 10 people with advanced retinitis pigmentosa in a small trial. Healthy Living Minnesota Asks CMS to Explain by October 15 How It Flagged 870 Medicaid Providers as High RiskMinnesota asked CMS to explain by Oct. 15 how it flagged 870 Medicaid providers as high risk. What is frozen and what patients should know. CDC Closes 2025–26 Flu Season with 198 Child Deaths as Early Activity Runs Highest on the West CoastCDC data close the 2025–26 flu season at 198 child deaths as early activity runs highest on the West Coast. Who is most at risk now? Hospital Pharmacies Must Stop Using Two Nationwide Lots of Brevital Anesthetic After Par Health Finds Cellulose in VialsPar Health recalled Brevital lots 86930 and 88623 after cellulose was found in vials. Steps hospitals must take and what sedation patients can ask. Northwest Indianapolis and Boone County Residents Told to Boil Water for 72 Hours After Main Break Drops PressureCitizens Energy issued a precautionary 72-hour boil advisory for northwest Indianapolis and part of Boone County after a main break cut off pressure. Covid – 19 FDA Proposes Requiring Companies to Report Food Additives That Now Reach Grocery Shelves Without Federal ReviewFDA has released its proposed GRAS rule requiring companies to notify the agency about food additives. Here is what the proposal does and does not do. Federal Regulators Warn Some Hair Dryer Brushes Lack the Part That Stops ElectrocutionCPSC warns hair dryer brushes sold on Walmart.com and TikTok Shop lack immersion protection. The seller has not agreed to a recall or refund. A Recalled Teething Toy Broke the Pattern Parents Were Told to Look ForA newly recalled pull-string teething toy has a different model number and design from earlier recalls, and one choking incident has been reported. Trying to Lower Blood Sugar, Cholesterol or Blood Pressure? Different Workouts Suited Different MarkersA pooled analysis of 53 trials found that different exercise types helped different metabolic markers. Most of the evidence was low certainty. Editorial Illustration via AI Share on Twitter Share on Facebook Share on Pocket Patients with bleeding blood vessel malformations in the gut who took GLP-1 drugs had 73% fewer hospitalizations for gastrointestinal bleeding than similar patients on standard medicines, according to research presented at the American College of Gastroenterology’s 2026 annual meeting in Nashville.

The finding could interest older adults with angiodysplasia, a condition that can cause repeated bleeding, anemia, and the need for blood transfusions. GLP-1 drugs, widely used for diabetes and weight loss, are not approved to treat it.

The data come from a conference abstract that has not yet been peer-reviewed. The study looked back at existing records and found an association, not proof that the drugs prevented bleeding.

Angiodysplasia occurs when small blood vessels in the digestive tract become swollen and fragile. It is mostly linked to aging and is more common in older adults, according to MedlinePlus. Some people have bleeding with bright red or black stools, while others have no visible bleeding and learn of the problem through iron deficiency anemia found on routine blood tests.

In most cases, bleeding stops on its own, but it can return. Treatment may include sealing the vessels during endoscopy, the injected drug octreotide, or, rarely, the drug thalidomide. Patients with recurrent bleeding can face repeated hospital stays, transfusions and procedures.

That is why researchers looked at whether medicines some patients already take might help. GLP-1 drugs, such as semaglutide, are prescribed for type 2 diabetes and obesity, and the patients in this study who used them had one of those conditions.

The study, abstract P6549, was among the meeting’s newsworthy abstracts selected by ACG. Its author contacts include Andrew D. Rhim, MD, of Emory University, and Rohit Goyal, MBBS. The team used real-world records and propensity matching, a statistical method that pairs patients with similar characteristics to make groups more comparable.

The researchers compared patients with symptomatic angiodysplasia who used GLP-1 receptor agonists with patients treated with current drug therapies, including octreotide and thalidomide. They excluded people with other risk factors for repeated endoscopies and frequent transfusions.

GLP-1 use was linked to a 73% lower risk of hospitalization for GI bleeding, a 65% lower risk of needing an endoscopy with treatment to stop bleeding, and a 73% lower risk of needing a blood transfusion. The authors suggested the drugs might counter the low-oxygen injury thought to drive the condition by affecting how blood vessels widen and grow, but that idea has not been tested.

MedicalDaily Evidence Check: This was a retrospective, observational study presented as a conference abstract. The publicly released summary did not list the number of patients, the specific GLP-1 drugs used, the length of follow-up, the data source or funding. It shows an association, not cause and effect, and it has not been peer-reviewed.

The authors were direct about the limits. In comments released by ACG, they said the findings do not establish causality or warrant a change in clinical practice, and they called for prospective studies to confirm the results. “Patients should not start or change medications based on these findings alone,” they wrote.

Observational studies like this one can be skewed by differences researchers cannot fully measure. Patients prescribed GLP-1 drugs may differ from those given octreotide or thalidomide in overall health, access to care, or how closely doctors monitor them. Only a randomized trial can show whether the drugs themselves reduce bleeding.

For patients who already take a GLP-1 drug for diabetes or obesity and also have angiodysplasia, the study is a reason to ask questions at the next visit, not a reason to change treatment. Common side effects of semaglutide include nausea and vomiting, and vomiting or diarrhea can lead to dehydration, which can be risky for frail older adults.

Cost and coverage are also barriers. GLP-1 drugs are expensive, and insurance coverage is generally tied to approved uses such as type 2 diabetes or, in some plans, obesity. Use for angiodysplasia would be off-label.

People with angiodysplasia should seek emergency care for black or bloody stools, dizziness, fainting, a fast heartbeat or shortness of breath, which can be signs of serious GI bleeding. Anyone with unexplained fatigue or anemia can ask a clinician whether a GI bleeding source has been ruled out.

The ACG meeting runs through Oct. 14, and full results may later appear in a peer-reviewed journal. Until a prospective study tests the idea, the finding remains a lead rather than a treatment option.

What did the study find? Patients with angiodysplasia who used GLP-1 drugs had 73% fewer GI bleeding hospitalizations than similar patients on standard therapies such as octreotide or thalidomide.

Does this prove GLP-1 drugs prevent bleeding? No. The study found an association in past records and cannot show cause and effect.

What is angiodysplasia? It is a condition in which small, fragile blood vessels in the digestive tract can bleed, sometimes causing anemia. It is more common in older adults.

Should I start a GLP-1 drug for angiodysplasia? No. The authors said patients should not start or change medications based on these findings alone.

Has the study been published? Not yet. It is a conference abstract that has not been peer-reviewed.

What symptoms need urgent care? Black or bloody stools, dizziness, fainting, a fast heartbeat or shortness of breath.